Eva-Maria Wagner-Drouet

32PUBLICATIONS
219CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene expression (incl. microarray and other genome-wide approaches)Respiratory diseasesTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Apr 06, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger, Dirk Heckl, Martin Hutter

|Dec 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.

Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire

|Oct 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.

Mohamad Mohty, Gerard Socié, Jeff Szer

|Sep 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party.

Agnieszka Piekarska, Mouad Abouqateb, William Boreland

|Aug 06, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings.

Johannes Schetelig, Henning Baldauf, Carina Rave

Pageof 6

Frequent Collaborators

10 joint publications

Friedrich Stölzel

9 joint publications

Mohamad Mohty

8 joint publications

Peter Dreger

7 joint publications

Wolfgang Bethge